APGE

Price to earnings forward of Apogee Therapeutics, Inc. – NASDAQ:APGE

Enterprise value to EBITDA forward of Apogee Therapeutics, Inc. – NASDAQ:APGE

Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Bill

Apogee Therapeutics CEO Henderson sells $10.6m in common stock

Apogee Therapeutics CMO Carl Dambkowski sells $3.5m in stock

Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition

AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.

Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger

Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer

Apogee: "Hold" On AbbVie $10.9B Buyout And Extended Half-Life IL-13 Zumilokibart For AD

AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apogee Therapeutics, Inc. (NASDAQ: APGE)

Apogee Therapeutics stock hits all-time high at 132.61 USD

Stocks making the biggest moves premarket: Apogee Therapeutics, SpaceX, Arcosa & more

Why is Apogee Therapeutics stock surging today?